Rafaèle Tordjman, MD, PhD, is Managing Partner at Sofinnova Partners. Prior to this, she worked as a research scientist at the Institut National de la Recherche Médicale (INSERM) in Cochin Hospital, Paris. Before joining INSERM, she was a medical doctor specializing in clinical hematology and internal medicine. She obtained her PhD, with high honors, in hematopoiesis and angiogenesis from the University Paris VII followed by a postdoctoral fellowship in immunology. Rafaèle obtained her medical degree and her specialization in Haematology and Internal Medicine as a five-year fellow in Paris University Hospitals. She also participated in the “Young Manager Program” at INSEAD. She has invested in and is on the board of Ascendis, DBV technologies, Flexion Therapeutics, Nucana Biomed, MedDay and ObsEva. She was also on the board of Corevalve, Endoart before it was successfully sold to Allergan Inc, of Preglem before the latter was successfully sold to Gedeon Richter and of HBI Ltd before being acquired by Meda.